Durvalumab Tolerability in Non–Small Cell Lung Cancer

0 Views
administrator
administrator
07/14/23

Discussing tolerability and adverse events of durvalumab. Understanding that early recognition and intervention is key to avoiding negative outcomes.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next